Genetic counselling and ethical issues with chromosome microarray analysis in prenatal testing

Area of Science:

• Medical Genetics
• Bioethics
• Prenatal Diagnosis

Background:

• Chromosome microarray analysis (CMA) surpasses classical karyotyping in detecting pathogenic chromosomal anomalies.
• CMA is poised to become a primary method for prenatal diagnosis.
• The detection of copy number variants (CNVs) with uncertain clinical significance presents ethical challenges in prenatal testing.

Purpose of the Study:

• To explore the ethical implications of incidental findings, specifically CNVs of uncertain significance, in prenatal CMA.
• To examine the justification for withholding uncertain genetic test results from pregnant women.
• To define informed choice in the context of prenatal CMA and address clinician responsibility regarding pregnancy terminations.

Main Methods:

• Ethical analysis of clinical scenarios involving prenatal CMA results.
• Review of principles of patient autonomy, informed consent, and non-directive genetic counseling.
• Consideration of the potential harms and benefits associated with disclosing uncertain genetic information.

Main Results:

• The study argues for the ethical imperative to disclose all information, including uncertain CNVs, to uphold patient autonomy.
• Withholding uncertain results is deemed ethically unjustifiable and paternalistic.
• Non-directive genetic counseling is crucial for facilitating informed decision-making by expectant parents.

Conclusions:

• Women undergoing prenatal CMA should receive comprehensive information, including uncertain findings, to make autonomous reproductive choices.
• Clinicians should support patient autonomy and avoid paternalism in managing uncertain prenatal genetic results.
• Effective, non-directive genetic counseling is essential for navigating the complexities of prenatal CMA.